Skip to main content

Drugs

Ausgabe 11/2017

Inhalt (10 Artikel)

Open Access Current Opinion

The Whole Price of Vancomycin: Toxicities, Troughs, and Time

Meghan N. Jeffres

Review Article

A Review of Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs?

Wendy L. St. Peter, Lori D. Wazny, Eric Weinhandl, Katie E. Cardone, Joanna Q. Hudson

Open Access Systematic Review

The Effects of Tamoxifen on Plasma Lipoprotein(a) Concentrations: Systematic Review and Meta-Analysis

Amirhossein Sahebkar, Maria-Corina Serban, Peter Penson, Camelia Gurban, Sorin Ursoniu, Peter P. Toth, Steven R. Jones, Giuseppe Lippi, Kazuhiko Kotani, Karam Kostner, Manfredi Rizzo, Jacek Rysz, Maciej Banach

Adis Drug Evaluation

Abatacept: A Review in Rheumatoid Arthritis

Hannah A. Blair, Emma D. Deeks

Adis Drug Evaluation

Eftrenonacog Alfa: A Review in Haemophilia B

Sheridan M. Hoy

AdisInsight Report

Cerliponase Alfa: First Global Approval

Anthony Markham

AdisInsight Report

Midostaurin: First Global Approval

Esther S. Kim

Erratum

Erratum to: JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects

Shubhasree Banerjee, Ann Biehl, Massimo Gadina, Sarfaraz Hasni, Daniella M. Schwartz

Aktuelle Ausgaben